Chamberlain College of Nursing and Walgreens partner on nurse education programs
DOWNERS GROVE, Ill. — Chamberlain College of Nursing and Walgreens are working together to provide Chamberlain’s advanced practice nursing students the opportunity to gain retail-based clinical practicum experience at Healthcare Clinic at select Walgreens locations nationwide, the companies announced Tuesday. In addition, the relationship offers Walgreens registered and advanced practice nurses a group tuition rate for Chamberlain’s post licensure degree programs to advance their education.
“Patients today are looking to community health care providers who offer convenient, cost-effective options for care, and this provides invaluable clinical experience for Chamberlain’s students,” state Heidi Wold, VP operations for Walgreens Consumer Solutions Group. “There’s great synergy between our organizations to make a difference in health care, creating a pipeline of advanced practice nurses who are prepared to serve the needs of patients in the communities where they live and work.”
“Advanced practice nurses in the retail health clinic setting provide services spanning personal wellness and prevention and disease management for a broad patient population ranging in age and ethnicity,” commented Carole Eldridge, director of graduate programs at Chamberlain College of Nursing. “This relationship gives registered nurses employed by Walgreens and Healthcare Clinic access to educational opportunities critical to this role and benefits Chamberlain’s advanced practice nursing students by offering necessary hands-on clinical experience.”
Through the relationship, students enrolled in Chamberlain’s Master of Science in Nursing Family Nurse Practitioner specialty track and Doctor of Nursing Practice degree programs may participate in a clinical practicum experience at Healthcare Clinic at select Walgreens locations.
Pfizer sues to protect Viagra from generic competition
NEW YORK — Pfizer has sued Torrent Pharmaceuticals in an effort to protect its erectile-dysfunction drug Viagra (sildenafil citrate) from generic competition, according to a Bloomberg News report published Tuesday.
Torrent has filed an aNDA with the Food and Drug Administration, challenging Pfizer’s patent that expires on Oct. 22, 2019.
According to the report, Pfizer and Teva Pharmaceuticals USA have reached a settlement that permits Teva to market a generic version of Viagra in the United States on Dec. 11, 2017.
Generic drugs slow pharma spending growth in Canada
OTTAWA, Ontario — Last year, $29.3 billion was spent on prescription drugs in Canada, but the annual growth rate was the second-lowest in more than 20 years, according to a new report by the Canadian Institute for Health Information released earlier this month.
This slower growth in spending — 2.3% in 2013 — was due to increased use of less-expensive generic drugs and related pricing policies. In total, prescription drugs accounted for 85% of the $34.5 billion that was spent on all drugs last year.
Generic drugs account for the majority of use but less than half of spending in public drug programs. In 2012, they made up 72.4% of claims but only 38.8% of spending.
Use of generics is increasing because several of the most commonly prescribed drugs are now available in generic form.
The report also found that the majority of public drug spending is for a small number of high-cost individuals. More than 60% of public drug money is used for 12% of Canadians, each of whom has $2,500-plus worth of prescription drugs paid for by public programs.